Sofinnova Capital VI, FCPR Insider Profile
4 Followers
Sofinnova Capital VI, FCPR, former Ten Percent Owner at BioAmber, holds 3.18M shares in Hookipa Pharma (Ticker: HOOK), holds 3.80M shares in BioAmber (Ticker: BIOAQ), holds 0.00 shares in Omthera (Ticker: OMTH). Most recently, Sofinnova Capital VI, FCPR Sold ― shares of Hookipa Pharma on Apr 23, 2021 for an estimated value of $3.81M.
Sofinnova Capital VI, FCPR's Trading History
| HOOKHookipa Pharma | Apr 23, 2021 | ― | Informative Sell | 3.81M | $3.65M | |
| BIOAQBioAmber | May 16, 2013 | ― | Uninformative Buy | ― | $197.74K | |
| OMTHOmthera | ― | ― | ― | ― |
You May Also Like
Sofinnova Capital VI, FCPR insider profile FAQ
What is the percentage of profitable transactions made by Sofinnova Capital VI, FCPR?
The percentage of profitable transactions made by Sofinnova Capital VI, FCPR is 50%.
What is the average return per transaction made by Sofinnova Capital VI, FCPR?
The average return per transaction made by Sofinnova Capital VI, FCPR is 22.60%.
What stocks does Sofinnova Capital VI, FCPR hold?
Sofinnova Capital VI, FCPR holds: BIOAQ, HOOK, OMTH stocks.
What was Sofinnova Capital VI, FCPR’s latest transaction?
Sofinnova Capital VI, FCPR’s latest transaction was an Informative Sell of $3.81M.
What was Sofinnova Capital VI, FCPR's most profitable transaction?
Sofinnova Capital VI, FCPR’s most profitable transaction was an Informative Sell of HOOK stock on April 23, 2021. The return on the trade was 87.70%.
What is Sofinnova Capital VI, FCPR's role in BioAmber?
Sofinnova Capital VI, FCPR's role in BioAmber is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
